Cholesterol Test Market Expected to Reach $18,441.91 million by 2031—Allied Market Research

According to a new report published by Allied Market Research, titled, “Cholesterol Test Market," The cholesterol test market size was valued at $8,537.52 million in 2021 and is projected to reach $18,441.91 million by 2031, growing at a CAGR of 8% from 2022 to 2031.

Cholesterol test, also referred to as a lipid panel or lipid profile is used to determine triglyceride and cholesterol levels in the blood. It can also help determine a person's risk of developing plaques, which are fatty deposits that can build up in the arteries and cause blocked or constrained blood flow throughout the body (atherosclerosis). A comprehensive cholesterol test is carried out to determine whether your cholesterol is high and to evaluate your risk of heart attacks, different types of heart disease, and blood vessel issues. A thorough cholesterol test includes the calculation of four blood fats: total cholesterol, triglycerides, low density lipoprotein cholesterol, and high-density lipoprotein cholesterol. 

The key factors that drive the growth of the cholesterol test market share are rise in prevalence of cardiovascular disease and obesity. Moreover, the sedentary lifestyle leading to the development of numerous diseases such as heart disease and increased awareness regarding routine testing and management of healthy cholesterol levels are further expected to boost the growth of the cholesterol test market trends during forecast period. However, lack of diagnostics laboratories and increasing regulatory policies are likely to hamper the growth of the cholesterol test market during the forecast period. Conversely, upsurge in number of gym and fitness club are expected to provide numerous opportunities for cholesterol test market growth during the forecast period. 

 By product type, the test kits segment dominated the market in 2021 and is expected to remain dominant during the forecast period, owing to increase in prevalence of cholesterol due to an unhealthy diet, rising obesity rates, and a lack of physical activity as people's lives become busier. In addition, the consumption of certain medications to treat conditions like high blood pressure, organ transplants, acne, HIV/AIDS, cancer, and irregular heartbeats can also result in HDL cholesterol which further propel the market growth.

By test type, the total cholesterol test segment dominated the cholesterol test industry in 2021 and is expected to remain dominant during the forecast period, owing to increase in prevalence of lifestyle disorders including cardiovascular disease (CVD) due to a larger adoption of a sedentary culture and the inability to prepare nutritious meals on a regular basis. 

By end user, the diagnostic centers segment dominated the market in 2021 and is expected to remain dominant during the forecast period, owing to increase in number of people being diagnosed with high total cholesterol. Moreover, regular health checkups without the doctors’ intervention further boost the market growth.

Region wise, North America has the highest market share in 2021 with highest CAGR during the forecast period. Owing to presence of large patient population, strong presence of key players, well developed healthcare infrastructure and higher number of research, development, & innovation activities. Asia pacific is projected to register the highest CAGR during the forecast period. The evolving healthcare regulatory landscape and an increase in the number of patients with heart disease are the key driving factors that boost the growth of the market in the region. 

Key findings of the study 

• On the basis of product type, the test kits segment dominated the market in 2021, and is expected to continue this trend during the forecast period. 

• On the basis of test type, the total cholesterol test segment is projected to grow at a CAGR during the forecast period. 

• On the basis of end user, the diagnostic centers segment is projected to grow at a CAGR during the forecast period. 

• Region-wise, North America garnered the largest revenue share in 2021. However, Asia-Pacific is anticipated to grow at the highest CAGR during the forecast period.